Clinicopathological and Immunophenotypic Characteristics of Series of ZNF384 Re-arranged Acute Leukemias
- PMID: 39469177
- PMCID: PMC11512947
- DOI: 10.1007/s12288-024-01755-5
Clinicopathological and Immunophenotypic Characteristics of Series of ZNF384 Re-arranged Acute Leukemias
Abstract
Rearrangement involving ZNF384 gene (ZNF384-r) is recently being described in acute leukemias. We present the clinic-pathological and immunophenotypic findings in a series of five cases of acute leukemia with ZNF384-r reported in our Institute between September 2020 to September 2023. Notably, while TCF3::ZNF384 fusion was the most frequently encountered abnormality, the fusion partner was not identified in two patients with ZNF384-r BCP-ALL. Immunophenotypically, patients presenting as B-cell precursor acute lymphoblastic leukemia (BCP-ALL) had a distinct profile characterized by weak or absent CD10 expression and the presence of myeloid markers such as CD13/CD33. Our findings underscore the importance of recognizing the distinct immunophenotypic features of ZNF384-r leukemias, particularly in cases presenting with atypical BCP-ALL or B/Myeloid mixed phenotype acute leukemia phenotypes. Moreover, these findings highlight the necessity for tailored diagnostic algorithms in clinical laboratories to facilitate the timely and accurate diagnosis of this clinically relevant leukemia subtype.
Keywords: BCP-ALL; Immunophenotyping; MPAL; TCF3-ZNF384 Fusion; ZNF384 Rearrangement.
© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2024.
Conflict of interest statement
Conflicts of Interest/Competing InterestsThe authors declare that they have no conflict of interest.
Figures
References
-
- Kurzer JH, Weinberg OK (2022) To B- or not to B-: a review of lineage switched acute leukemia. Int J Lab Hematol 44:64–70 - PubMed
-
- Kapadia AB, Sreedharanunni S, Muhammed S, Karmakar I, Rana S, Sharma P et al (2020) Emergence of a prominent myeloid clone in a ZNF384-rearranged B-cell precursor acute lymphoblastic leukaemia post-corticosteroid pre-phase therapy. Pediatr Blood Cancer 67:e28513 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous